Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Purchase of 3,420 RNTX shares, $3.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Rein Therapeutics, Inc. (RNTX) | Purchase | 3,420 | $3.6K |
| Jul 23, 2025 | Rein Therapeutics, Inc. (RNTX) | Grant/Award | 17,500 | n/a |
| Dec 6, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 35,000 | n/a |
| Aug 22, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 2,725 | n/a |
| Mar 1, 2024 | AILERON THERAPEUTICS INC (ALRN) | Grant/Award | 2,725 | n/a |
| Jun 17, 2022 | AILERON THERAPEUTICS INC (ALRN) | Grant/Award | 54,500 | n/a |
| Jun 17, 2021 | AILERON THERAPEUTICS INC (ALRN) | Grant/Award | 96,000 | n/a |
| Jun 18, 2020 | AILERON THERAPEUTICS INC (ALRN) | Grant/Award | 12,500 | n/a |
| Jun 10, 2020 | AILERON THERAPEUTICS INC (ALRN) | Purchase | 227,272 | $250.0K |